Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase
- Detalles
- Categoría de nivel principal o raíz: Bibliografía recomendada
- COMISIÓN DE VIH E ITS
- Autores: Llibre JM, Brites C, Cheng CY, Osiyemi O, van Wyk J et al
- Revista: Clin Infect Dis. 2023 Feb 18;76(4):720-729.
- DOI: https://doi.org/10.1093/cid/ciac130